Hongying Wang
Corporate Officer/Principal chez China Nuokang Bio-Pharmaceutical, Inc.
Profil
Hongying Wang is a professional who has worked as an Executive Vice President at China Nuokang Bio-Pharmaceutical, Inc. since 2007.
Prior to this, she worked as a Technology Supervisor at Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd.
Ms. Wang holds an MBA from Northeastern University, which she received in 2006, and an undergraduate degree from Liaoning University, which she received in 1996.
Postes actifs de Hongying Wang
| Sociétés | Poste | Début |
|---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
 China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Corporate Officer/Principal | 23/11/2009 |
Anciens postes connus de Hongying Wang
| Sociétés | Poste | Fin |
|---|---|---|
| Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd. | Corporate Officer/Principal | - |
Formation de Hongying Wang
| Northeastern University | Masters Business Admin |
| Liaoning University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
| Shenyang Lantian Group Xinbei Pharmaceutical Co., Ltd. |
